Exchange: NYSE
Industry: Pharmaceuticals & Biotechnology
Last Trade: 4:00 PM ET 5/24/2012
Last 10 Quotes:
What's This?
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.00 | 0.00 | 0.00 |
| EPS, GAAP | 0.00 | 0.00 | 0.00 |
| Consensus Estimate | 0.00 | 0.00 | 0.00 |
| ELN | Industry Average | |
| P/E (TTM) | 0.00 | NA |
| P/E (Forward) | 0.00 | NA |
| PEG Ratio | 0.00 | 0.00 |
| Price/Sales | 0.00 | 0.00 |
| Beta | 0.00 | 0.00 |
| 12:26 PM | 5/1/2012 | 2nd UPDATE: Biogen 1Q Profit Up, But Hurt By Purchasing Issue |
| 10:54 AM | 5/1/2012 | UPDATE: Biogen 1Q Profit Up, But Hurt By Purchasing Issue |
| 5/22/2012 | Eaton's Cooper Pact Swaps U.S. Tax Rate for Ireland's (WSJ.com) |
| 3/30/2012 | Describing Ireland's situation as a recession is no longer accurate. It's now a full-fledged depression. (The Motley Fool) |
| 3/27/2012 | Nasdaq, S&P confirm the 2012 uptrend (MarketWatch.com) |
| 3/17/2012 | Why Joseph McNay Likes New Energy, Content, and Smartphones (Barrons.com) |
| 3/8/2012 | Stocks that give retirees what they want are incredibly valuable. (The Motley Fool) |
| 3/1/2012 | Elan Keeps Pilot in Place (WSJ.com) |
| 2/29/2012 | An ambitious federal program aims to develop viable treatments for Alzheimer's disease. (The Motley Fool) |
| 2/25/2012 | Is Help Near? (Barrons.com) |
![[sm061210things]](http://s.wsj.net/public/resources/images/PF-AC562_sm0612_C_20120514113337.jpg)
![[sm0612wedding4]](http://s.wsj.net/public/resources/images/PF-AC579_sm0612_C_20120515172853.jpg)
![[sm0612strat]](http://s.wsj.net/public/resources/images/PF-AC580_sm0612_C_20120515180019.jpg)
![[sm0612roi]](http://s.wsj.net/public/resources/images/PF-AC573_sm0612_C_20120515125902.jpg)
